<?xml version="1.0" encoding="UTF-8"?>
<p>Lopinavir/Ritonavir is a protease inhibitor approved for the treatment of HIV (
 <xref rid="B108" ref-type="bibr">108</xref>). Lopinavir was approved for the treatment of SARS-CoV during the epidemic of 2003 because it showed inhibitory activity against the virus 
 <italic>in vitro</italic>. Lopinavir was also used against MERS-CoV because it has inhibitory activity against the virus both 
 <italic>in vitro</italic> and in an animal models (
 <xref rid="B109" ref-type="bibr">109</xref>, 
 <xref rid="B110" ref-type="bibr">110</xref>). Lopinavir is used in combination with ritonavir because it increases the plasma half-life of lopinavir inhibiting the cytochrome P450 (
 <xref rid="B111" ref-type="bibr">111</xref>).
</p>
